title: Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors.
authors.affiliation: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
authors.forename: Hayan
authors.initials: H
authors.lastname: Jouni
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Mary C
authors.initials: MC
authors.lastname: Aubry
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Martha Q
authors.initials: MQ
authors.lastname: Lacy
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: S
authors.initials: S
authors.lastname: Vincent Rajkumar
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Shaji K
authors.initials: SK
authors.lastname: Kumar
authors.affiliation: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Frye
authors.affiliation: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
authors.forename: Joerg
authors.initials: J
authors.lastname: Herrmann
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D001896:Boron Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D066126:Cardiotoxicity; D004452:Echocardiography; D005998:Glycine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006333:Heart Failure / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001896:Boron Compounds; D011480:Protease Inhibitors; C548400:ixazomib; D005998:Glycine